ALTERATIONS IN THE THYMOPOIESIS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS

REFERENCES

• Bach J. F. Current concepts of autoimmunity. Review of Neurology (Paris) 2002; 158(10)881–886
   PubMedGoogle Scholar
• Bendelac A., Rivera M. N., Park S.-H., Roark J. H. Mouse CD1-specific NK1 T cells: Development, specificity and function. Annual Review of Immunology 1997; 15: 535–562, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Budd R. C., Mixter P. F. The origin of CD4–CD8-TCRab+ thymocytes: A model based on T-cell receptor avidity. Immunology Today 1995; 16(9)428–431, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Casley-Smith J. R. Expressing stereological results "per cm3" is not enough. Journal of Pathology 1988; 156(3)263–265, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Chan S. H., Cosgrove D., Waltzinger C., Benoist C., Mathis D. Another view of the selective model of thymocyte selection. Cell 1993; 73(2)225–236, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Damjanović M., Vidić-Danković B., Kosec D., Isaković K. Thymus changes in experimentally induced myasthenia gravis. Autoimmunity 1993; 15(3)201–207, [CSA]
   PubMedGoogle Scholar
• Drachman D. B., Adams R. N., Stanley E. F., Pestronk A. Mechanisms of acetylcholine receptor loss in myasthenia gravis. Journal of Neurology Neurosurgery and Psychiatry 1980; 43(7)601–610
   PubMedGoogle Scholar
• Durelli L., Ferrio M. F., Massazza U., Cavallo R., Ferri R., Bergamini L., Maggi G., Engel A. G., Lambert E. H., Howard F. M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: Ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clinic Proceedings 1977; 52(5)267–280
   PubMedGoogle Scholar
• Eymard B., Berrih-Aknin S. Role of the thymus in the physiopathology of myasthenia. Revue Neurologique 1995; 151(1)6–15, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Fridkis-Hareli M., Eren R., Sharp A., Abel L., Kukulansky T., Globerson A. MHC recognition in colonization of the thymus by bone marrow cells. Cellular Immunology 1993; 149(1)91–98, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Fujii N., Itoyama Y., Goto I. Increase in differentiated type of T lineage cells in the myasthenic thymus: Two-color fluorocytometric analysis. Annals of Neurology 1990; 27(6)642–646, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ichikawa Y., Shimizu H., Yoshida M., Arimori S. Two-color flow cytometric analysis of thymic lymphocytes from patients with myashenia gravis and/or thymoma. Clinical Immunology and Immunopathology 1992; 62(1)91–96, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Jameson S. C., Hogquist K. A., Bevan M. J. Positive selection of thymocytes. Annual Review of Immunology 1995; 13: 93–126, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kendall M. D., Al-Shawaf A. A. Innervation of the rat thymus gland. Brain, Behaviour and Immunity 1991; 5(1)9–28, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Krolick K., Urso O. Analysis of helper-T-cell function by acetylcholine receptor-reactive cell lines of defined AChR-subunit specificity. Cellular Immunology 1987; 105(1)75–85, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lennon V. A., Lindstrom J. M., Seybold M. E. Experimental autoimmune myasthenia gravis: Cellular and humoral immune responses. Annals of the New York Academy of Sciences 1976; 274: 283–299, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lind E. F., Prockop S. E., Porritt H. E., Petrie H. T. Mapping precursor movement through the postnatal thymus reveals specific microenvironments support-ing defined stages of early lymphoid development. Journal of Experimental Medicine 2001; 194(2)127–134, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Lindstrom J. M., Lennon V. A., Seybold M. E., Whittingham S. Experimental autoimmune myasthenia gravis and myasthenia gravis: Biochemical and immunochemical aspects. Annals of the New York Academy of Sciences 1976; 274: 254–274, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• MacDonald H. R., Radke F., Wilson A. T cell specification and alfa-beta/gamma-delta lineage commitment. Current Opinion in Immunology 2001; 13(2)219–224, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Machi M., Itoyama Y., Goto I., Kuroiwa Y. Surface phenotypes of lymphoid cells altered in the human myasthenic thymus. Neurology 1988; 38(4)592–596, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mehr R., Perelson A. S., Fridkis-Hareli M., Globerson A. Regulatory feedback pathways in the thymus. Immunology Today 1997; 18(12)581–585, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Moulian N., Wakkach A., Guyon T., Poea S., Aissaoui A., Levasseur P, Cohen-Kaminsky S., Berrih-Aknin S. Respective role of thymus and muscle in autoimmune myasthenia gravis. Annals of the New York Academy of Sciences 1998; 841: 397–406, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• PejcÚić-Karapetrović B., Kosec D., Leposavić G. Differential effects of male and female gonadal hormones on the intrathymic T cell maturation. Developmental Immunology 2001; 8(3–4)305–317, [CSA]
   PubMedGoogle Scholar
• Petrie H. T., Hugo P., Scollay R., Shortman K. Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4 and CD8 acquisition in vivo and in vitro. The Journal of Experimental Medicine 1990; 172(6)1583–1588, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Poussin M. A., Christadoss P. Cellular mechanisms of target antigen attack in experimental autoimmune myasthenia gravis. Myasthenia Gravis: Disease mechanisms and immunointervention, P. Christados. Narosa Publishing House, New Delhi 2000; pp. 59–72
   Google Scholar
• Reinhard C., Melms A. Normalization of elevated CD4–/CD8– (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma. Annual Neurology 2000; 48(4)603–608, [CROSSREF]
   PubMedGoogle Scholar
• Rodewald H.-R., Fehling H. J. Molecular and cellular events in early thymocyte development. Advances in Immunology 1998; 69: 1–112, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Roncarolo M. G., Levings M. K. The role of different subsets of T regulatory cells in controlling autoimmunity. Current Opinion in Immunology 2000; 12(6)676–683, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Scollay R., Godfrey D. I. Thymic emigration: Conveyor belts or lucky dips?. Immunology Today 1995; 16(6)268–273, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Seddon B., Mason D. The third function of the thymus. . Immunology Today 2000; 21(2)95–99, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Shelton G. D. Acquired myasthenia gravis: What we have learned from experimental and spontaneous animal models. Veterinary Immunology and Immuno-pathoogy 1999; 69(2)239–249, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Shenoy M., Kaul R., Goluszko E., David C., Christados P. Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis. The Journal of Immunology 1994; 153(11)5330–5335, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shortman K., Egerton M., Spangrude G. J., Scollay R. The generation and fate of thymocytes. Seminars in Immunology 1990; 2(1)3–12, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Taams L. S., Wauben H. M. Anergic T cells as active regulators of immune response. Human Immunology 2000; 61(7)633–639, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Truffault F., Cohen-Kaminsky S., Khalil I., Levasseur P., Berrih-Aknin S. Altered intrathymic T-cell repertoire in human myasthenia gravis. Annals of Neurology 1997; 41(6)731–741, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Vidić-Danković B., Kosec D., Damjanović M., Apostolski S., Isaković K., Bartlett R. R. Leflunomide prevents the development of experimentally induced myasthenia gravis. International Journal of Immunopharmacology 1995; 17(4)273–281, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vincent A., Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. Journal of Neurology, Neurosurgery and Psychiatry 1985; 48(12)1246–1252
   PubMedGoogle Scholar
• Wang R., Wang-Zhu Y., Grey H. Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proceedings of the National Academy of Sciences of the United States of America 2002; 99(4)2181–2186, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Weibel E. R. Stereological methods. Practical methods for biological morphometry. Academic Press, London 1979; Vol. 1
   Google Scholar
• Westermann J., Smith T., Peters U., Tschernig T., Pabst R., Steinhoff G., Sparshott S. M., Bell E. B. Both activated and non-activated leucocytes from the periphery continuously enter the thymic medulla of adult rats: phenotypes, source and magnitude of traffic. European Journal of Immunology 1996; 26(8)1866–1874, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Zhang G. X., Ma C. G., Link H., Olsson T. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats. European Journal of Immunology 1995; 25(5)1191–1198, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zhang G.-X., Xiao B.-G., Bakhiet M., van der Meide P., Wigzell H., Link H., Olsson T. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis. The Journal of Experimental Medicine 1996; 184(2)349–356, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zhang G.-X., Xiao B.-G., Yu L.-Y., van der Meide P. H., Link H. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. Journal of Neuroimmunology 2001; 113(1)10–18, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar